This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
KOL Webinar on the Need for Concentrated and Rapid Acting Insulin
The Need for Concentrated and Rapid Acting Insulin Treatments in Diabetes Care.
This webinar will bring together four world-class experts in the field of diabetes care, who will discuss the AT278 clinical data as well as the clinical and patient need.
Moderated by: Jay Skyler, Professor of Medicine, Pediatrics & Psychology, in the Division of Endocrinology Diabetes & Metabolism at the University of Miami, USA.
Speakers and session titles:
Wendy Lane: The increased need for rapid-acting concentrated insulin products for people living with type 2 diabetes from a clinical perspective
Davida Kruger: The benefits of concentrated insulin from the patient perspective
Thomas Pieber: Summary of the results from Arecor’s phase 1 clinical trial of its ultra-rapid, ultra-concentrated insulin product candidate, AT278
Time:
26 May 2022 | 16:00-17:30 CEST (BST +1) / 10:00 – 11:30 ESDT